*Some Market data delayed by 15 mins.

ImmunityBio, Inc. Common Stock

Symbol: IBRX (NASDAQ)
6.65 ▼ (-0.73%) -0.049

Company Description:
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: United states and Europe. Key revenue is generated from Europe.

Key Stats
  • Today's Open: $6.77
  • Today's High: $6.864
  • Today's Low: $6.605
  • Today's Volume: 1.60M
  • Yesterday Close: $6.7
  • Yesterday High: $6.8
  • Yesterday Low: $6.61
  • Yesterday Volume: 1.75M
  • Last Min Volume: 0
  • Last Min High: $6.654
  • Last Min Low: $6.651
  • Last Min VWAP: $0
Company Profile
  • Name: ImmunityBio, Inc. Common Stock
  • Website: https://www.immunitybio.com
  • Listed Date: 2021-03-10
  • Location: SAN DIEGO, CA
  • Market Status: Active
  • CIK Number: 0001326110
  • SIC Code: 2836
  • SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
  • Market Cap: $4.58B
  • Round Lot: 100
  • Outstanding Shares: 691.57M
  • Asset Type: CS
RECENT FILINGS FOR IBRX
Filing DateFiling TypeFormat
2024-06-20S-8View
2024-06-134View
2024-06-134View
2024-06-134View
2024-06-134View
2024-06-134View
2024-06-134View
2024-06-128-KView
2024-05-0910-QView
2024-05-02EFFECTView
2024-04-30CORRESPView
2024-04-29DEFA14AView
2024-04-29DEF 14AView
2024-04-29ARSView
2024-04-238-KView
2024-04-17S-3ASRView
2024-04-03UPLOADView
2024-03-29S-3View
2024-03-28CORRESPView
2024-03-1910-KView
Latest News

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.